Moussa Youdim#


Moussa Youdim
Membership Number:7219
Membership type:ORDINARY
Section:BASIC AND CLINICAL TRANSLATIONAL SCIENCES
Elected:2025
Main Country of Residence:ISRAEL
Homepage(s):http://Youdim.com





Present and Previous Positions

  • 1966 1972 Senior Research Associate, Postgraduate Medical School, University of London, London, England.
  • 1972 1973 Wellcome Fellow, Unit de la Neurpharmacologie et Biochemique, College de France, 11 Place Marcelin Berthelot, Paris, France.
  • 1973 1977 M.R.C. Clinical Pharmacology Unit and University Department of Clinical Pharmacology and member of Faculty of Clinical Medicine, University of Oxford, Radcliffe Infirmary, Oxford, England.
  • 1977-2009 Professor of Pharmacology, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • 1976 1994 Chairman of Pharmacology, Faculty of Medicine, Technion lsrael Institute of Technology, Haifa, Israel.
  • 1983 1997 Professor of Biomedical Engineering, Department of Biomedical Engineering, Technion lsrael institute of Technology, Haifa, Israel.
  • 1984 2009 Finkelstein Professor of Life Sciences, Faculty of Medicine, Technion lsrael Institute of Technology, Haifa, Israel.
  • 1984 1991 Professor of Pharmacology, Uniformed Armed Forces University, Washington DC, USA.
  • 1992 1994 Visiting Professor of Pharmacology, University of Florence, Florence, Italy.
  • 1996-2009 Director of Eve Topf Neurodegenerative Diseases Center of Excellence for Teaching and Research, Technion-Faculty of Medicine, Technion-Rappaport Family Faculty of Medicine
  • 1996-2009 Director of USA National Parkinson Foundation Center of Excellence, Technion-
  • Rappaport Faculty of Medicine.
  • 2009 Professor Emeritus, Technion-Rappaport Family Faculty of Medicine
  • 2008-2010 Distinguished Chair Professor, Department of Applied Biology and Modern Chinese
  • Medicine, PolyTechnic Uinversity, Hong Kong.
  • 2008-2009 Distinguished Honorary Professor, Department of Anatomy, Hong Kong University
  • Hong Kong.
  • 2008-present Distinguished Scientific Professor, World Central Yonsei University, Seoul, South
  • Korea
  • 2010-present Distinguished Honorary Professor, Materica Medica of Chinese Academy of Sciences Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • 2010-present Distinguished Honorary Professor, Shanghai Rugin Univeristy Medical School, Shanghai, China.
  • 2010-present Elected Member of Leopoldina German Academy of Sciences (Leopoldina.), Germany

Fields of Scholarship
  • Drug development
  • Multi target s drugs possessing neuroprotective and neurorestorative activities.
  • Alzheimer's disease
  • Molecular biology
  • Development of monoamine oxidase B inhibitors as anti Parkinson drugs, selegiline, Azilect
  • Parkinson's Disease
  • Iron dysregulation in brain function.
  • Neurodegenerative diseases


Honours and Awards

  • 1974. Anna-Monika Prize in the field of neurobiology and the treatment of depressive disorders (Basel, Switzerland).
  • • 1974. British Migraine Association Special Gold Medal (London, England).
  • • 1978. The Homayoon (Royal) Medal (Teheran, Iran).
  • • 1980. Israel National Psychobiology Center Research Achievement Prize (Jerusalem, Israel).
  • • 1986. Michael Landau Research Prize (Tel Aviv, Israel).
  • • 1990. Senator Burda International Prize for Parkinson’s Disease (Vienna, Austria).
  • • 1991. Claudius Galenus Gold Medal Prize for Parkinson Disease, l-Deprenyl (selegiline) Drug of the Year (Berlin, Germany).
  • • 1991. Deutscher Neuropharmakologie (AGNP) Prize (Nurenburg, Germany).
  • • 1991. Eli Lilly Prize for Neuropsychopharmacology (Indianapolis, USA).
  • • 1993. The New England Prize for Excellence In Science (Boston, USA).
  • • 1991-1998 Fogarty International Scholar In Residence at Fogarty Center For Advanced Study In Human Health NIH, NIDDK and NIMH (Bethesda, U
  • • 1994. Henning Anderson Prize (Stockholm, Sweden)
  • • 1995. Hershel Rich Innovation Prize, Technion (Haifa, Israel)
  • • 1997. “Honoree Causa” Honorary Doctor of Philosophy. Semmelweiss University Medical School (Budapest, Hungary)
  • • 2000. Hershel Rich Innovation Prize, Technion, (Haifa, Israel).
  • • 2006. Herschel Rich Innovation Prize discovery of TVP-1022 a cardioprotective drug. Technion (Haifa, Israel).
  • • 2006. Henry Taub Prize for Excellence in Research, Technion, (Haifa, Israel)., Hi
  • disease With Neurorestorative with drugs. Mount Sinai School of Medicine, (New York, USA).
  • • 2007. Hirotaro Narabayashi Lecture. 17th International Congress of Parkinson’s Disease, (Amsterdam, Holland).
  • • 2007. World Federation of Neurology Award for Contribution to Parkinson’s Disease, 17th International Congress of Parkinson’s Disease, (Amsterdam, Holland).
  • • 2008. Distinguished Honorary Professor, University of Hong Hong, Hong Kong.
  • • 2008-2010 Distinguished Chair Professor, PolyTechnic University of Hong Kong University, (Hong Kong, China)
  • • 2009-2014. Distinguished Scientific Professor of Neurobiology, Yonsei World Central University Department of Neuroibology, (Seoul, South Korea).
  • • 2010 European College Neuropsychopharmacology(ECNP) Life Time Achievement Neuropsychopharmacology Prize, (Amsterdam, Netherland).
  • • 2010 Elected Member of Leopoldina German Academy of Sciences (Halle, Germany).
  • • 2011. EMET Prize for Brain Sciences, (Jerusalem, Israel).
  • • 2011. Elected A Fellow of American College of Neuropsychopharmacology, USA.
  • • 2012. Giant Pioneer of Catecholamine Research Prize, 10th International Congress of Catecholamines, (Asilomar, USA).
  • • 2012. CINP (International College of Neuropsychopharmacology) Pioneering Neuropsychopharmacology Prize, (Stockholm, Sweden).
  • • 2012. The Arvid Carlsson Medal, (Stockholm, Sweden).
  • • 2013. Elected Honorary Member of Israel Society for Neuroscience.
  • • 2022. The Israel Prize In life Sciences, (Jerusalem, Israel).
  • • 2023. The Maimonides Award, Rambam Hospital, (Haifa, Israel).
  • • 2024. The Tel Aviv University Aufzien Center and Israel Parkinson Association Parkinson Prize, (Tel Aviv, Israel

Imprint Privacy policy « This page (revision-6) was last changed on Thursday, 5. June 2025, 08:34 by Kaiser Dana
  • operated by